School of Engineering
Showing 4,001-4,010 of 5,904 Results
-
Jan B. Pietzsch, PhD
Affiliate, Management Science and Engineering
BioDr. Pietzsch is co-founder, President and CEO of Wing Tech Inc., an independent, international health economics core lab and consultancy focused on value assessment of novel medical technologies and therapies. At Stanford, he holds an appointment as Adjunct Professor of Management Science and Engineering and serves as Director, Health Economics and Value, at the Stanford Mussallem Center for Biodesign, a globally leading program in health technology innovation. Dr. Pietzsch received his academic training at Stanford University (Ph.D., M.S.) and at the University of Karlsruhe, Germany (Dipl.-Wi.Ing.).
-
Ashton Pihl
Ph.D. Student in Civil and Environmental Engineering, admitted Summer 2025
BioI am a first-year PhD Student in the Baker Coastal Lab researching surf-zone circulation generated by short-crested breaking waves. I am interested in studying the along-crest variability in energy dissipation, the unsteady structure associated with injected vertical and horizontal vorticity, and the evolution of vertical vorticity structures linked to the shoreward propagation of bores using laboratory experimental methods and theoretical analysis.
-
Mert Pilanci
Assistant Professor of Electrical Engineering
Current Research and Scholarly InterestsDr. Pilanci's research interests include neural networks, machine learning, mathematical optimization, information theory and signal processing.
-
Rebecca Pinals
Assistant Professor of Chemical Engineering
BioThe brain is a fascinatingly complex and delicate system of biomolecules, cells, and dynamic interactions that must be carefully maintained to support human health. When this balance is disrupted, disease can arise. Neurodegenerative dementias including Alzheimer’s disease are highly prevalent and profoundly devastating, yet remain largely untreatable or incurable.
The Pinals Lab engineers neuro-models and nano-tools to uncover mechanisms of neurodegenerative disease and intervene to halt—and even reverse—disease progression. A particular emphasis of our work is on the blood–brain barrier (BBB), the vascular interface that serves as the molecular gateway into the brain. We leverage human induced pluripotent stem cells (iPSCs) to build 3D cellular systems, providing a platform to recapitulate human brain properties and pathologies. In parallel, we design nanoparticles to report on real-time neurochemical processes, enabling unprecedented access to dynamic and spatially resolved biomolecular phenomena, and to modulate disease states. By integrating advanced human brain tissue models with rationally designed nanotechnologies, we aim to generate fundamental insights and tools that translate into meaningful impacts for human health.
